Barrington Nutritionals (Harrison, NY) has introduced a cold-pressed black seed (Nigella sativa) oil standardized to 3% thymoquinone-the first of its kind, says the firm. Branded ThymoQuin, the oil was developed by nutritional supplement company TriNutra without the use of solvents and heat, instead using a slow, cold-press extraction process that yields the highest possible thymoquinone content. The product has been clinically tested, the firms say, demonstrating benefits for the support of cardiovascular health and inflammatory response.
“Nigella sativa oil has been used for over 2,000 years and has been referred to as the blessing seed,” said Morris Zelkha, TriNutra co-founder, in a press release. “Our standardized cold-press black seed oil, ThymoQuin, exhibits superior potency and support for healthy inflammatory activity when compared to other Nigella sativa oil products on the market.”
TriNutra also ensures farm-to-shelf traceability through a Nigella sativa breeding program that provides information about the history of the farm, varieties of Nigella sativa produced, cultivation and harvesting conditions, seed storage, and processing.
“ThymoQuin has also been clinically shown to have synergistic effects when combined with other ingredients such as omega-3,” said Chris Holland, vice president of sales at Barrington Nutritionals, in a press release. “These synergistic effects will help our customers create more effective formulations for the end consumer.”